Business Description
Allergy Therapeutics PLC
ISIN : GB00B02LCQ05
Description
Allergy Therapeutics PLC is active in the healthcare sector in the United Kingdom. It is a pharmaceutical company mainly engaged in the treatment and prevention of allergies with aluminum-free products. The company's geographical segment includes Central Europe; Southern Europe and the Rest of the World. It generates maximum revenue from Central Europe which includes Germany and other countries.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.37 | |||||
| Equity-to-Asset | 0.38 | |||||
| Debt-to-Equity | 0.37 | |||||
| Debt-to-EBITDA | -0.25 | |||||
| Piotroski F-Score | 1/9 | |||||
| Altman Z-Score | -2.92 | |||||
| Beneish M-Score | -4.04 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -8.5 | |||||
| 3-Year Book Growth Rate | -64.8 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 37.79 | |||||
| 9-Day RSI | 53.29 | |||||
| 14-Day RSI | 57.48 | |||||
| 6-1 Month Momentum % | 90.07 | |||||
| 12-1 Month Momentum % | -57.12 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.4 | |||||
| Quick Ratio | 0.93 | |||||
| Cash Ratio | 0.54 | |||||
| Days Inventory | 165.86 | |||||
| Days Sales Outstanding | 54.82 | |||||
| Days Payable | 185.21 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -2.6 | |||||
| Shareholder Yield % | -38.65 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 52.54 | |||||
| Operating Margin % | -72.92 | |||||
| Net Margin % | -94.29 | |||||
| FCF Margin % | -67.32 | |||||
| ROE % | -226.59 | |||||
| ROA % | -72.62 | |||||
| ROIC % | -96.92 | |||||
| ROC (Joel Greenblatt) % | -170.16 | |||||
| ROCE % | -88.53 | |||||
| Years of Profitability over Past 10-Year | 5 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 0.7 | |||||
| PB Ratio | 4.75 | |||||
| Price-to-Tangible-Book | 2.85 | |||||
| EV-to-EBIT | -3.06 | |||||
| EV-to-Forward-EBIT | -2 | |||||
| EV-to-EBITDA | -3.39 | |||||
| EV-to-Forward-EBITDA | -1.08 | |||||
| EV-to-Revenue | 2.48 | |||||
| EV-to-Forward-Revenue | 0.16 | |||||
| EV-to-FCF | -3.69 | |||||
| Price-to-Median-PS-Value | 0.15 | |||||
| Earnings Yield (Greenblatt) % | -32.68 | |||||
| FCF Yield % | -26.39 | |||||
| Forward Rate of Return (Yacktman) % | -3.07 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Allergy Therapeutics PLC Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil £) | 53.258 | ||
| EPS (TTM) (£) | -0.057 | ||
| Beta | 1.19 | ||
| Volatility % | 220.24 | ||
| 14-Day RSI | 57.48 | ||
| 14-Day ATR (£) | 0.002524 | ||
| 20-Day SMA (£) | 0.028635 | ||
| 12-1 Month Momentum % | -57.12 | ||
| 52-Week Range (£) | 0.008 - 0.0625 | ||
| Shares Outstanding (Mil) | 4,766.44 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 1 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Allergy Therapeutics PLC Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Allergy Therapeutics PLC Stock Events
| Event | Date | Price(£) | ||
|---|---|---|---|---|
| No Event Data | ||||
Allergy Therapeutics PLC Frequently Asked Questions
What is Allergy Therapeutics PLC(LSE:AGY)'s stock price today?
The current price of LSE:AGY is £0.03. The 52 week high of LSE:AGY is £0.06 and 52 week low is £0.01.
When is next earnings date of Allergy Therapeutics PLC(LSE:AGY)?
The next earnings date of Allergy Therapeutics PLC(LSE:AGY) is 2024-09-27 Est..
Does Allergy Therapeutics PLC(LSE:AGY) pay dividends? If so, how much?
Allergy Therapeutics PLC(LSE:AGY) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers